论文部分内容阅读
Overexpression of anti-apoptotic protein Bcl-2 is involved in therapy-resistance in hepatocellular carcinoma (HCC).The BH3-mimetic ABT-737, a Bcl-2 inhibitor, has shown promising antitumor efficacy in vitro and in vivo.